Physician profile
Ameya A Asarkar
NPI 1215484647
$8,376.59
in general payments reported to CMS, 2019-2025
25 companies · $1,754 in 2025
The $1,754 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $151 · 2021: $867 · 2022: $1,578 · 2023: $1,731 · 2024: $2,087 · 2025: $1,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,534 · Travel and Lodging: $37.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,533.92 |
| Travel and Lodging | $37.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,115.34 | 2021-2025 | Inspire |
| Depuy Synthes Sales INC. | $1,284.18 | 2019-2025 | Trumatch, Matrixmidface |
| Intuitive Surgical, INC. | $1,054.11 | 2022-2024 | |
| Medtronic, INC. | $737.46 | 2023-2025 | Nim Vital, Stealthstation S8 Platform, Propel |
| Intersect Ent, INC. | $205.68 | 2019-2021 | |
| Genzyme Corporation | $198.48 | 2022-2025 | |
| Olympus America INC. | $194.32 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $163.15 | 2020-2023 | Dupixent |
| Medtronic USA, INC. | $151.13 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.36 | 2023-2024 | Ofev |
| Genentech USA, INC. | $144.18 | 2023-2025 | Xolair |
| Axogen | $134.61 | 2021-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Davol INC. | $125.00 | 2023 | Phasix Mesh |
| Integra Lifesciences Corporation | $123.37 | 2020 | |
| Tempus Ai, INC | $118.66 | 2024-2025 | Xt Cdx |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $100.27 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Inogen, INC. | $73.61 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Astrazeneca Pharmaceuticals LP | $70.46 | 2023-2025 | Tezspire, Airsupra |
| Livanova USA, INC. | $58.83 | 2025 | Thn Sleep Therapy |
| Takeda Pharmaceuticals U.S.A., INC. | $54.54 | 2022-2024 | Glassia |
| Grifols USA, LLC | $36.05 | 2024-2025 | Prolastin-C Liquid |
| Electromed, INC. | $28.73 | 2025 | Smartvest |
| Aerin Medical INC. | $28.05 | 2022 | |
| Amag Pharmaceuticals, INC. | $18.86 | 2019 | |
| Covidien LP | $13.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ameya Asarkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.